257 related articles for article (PubMed ID: 33607158)
21. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway.
Xu B; Wang T; Xiao J; Dong W; Wen HZ; Wang X; Qin Y; Cai N; Zhou Z; Xu J; Wang H
Biochem Pharmacol; 2019 May; 163():234-249. PubMed ID: 30797872
[TBL] [Abstract][Full Text] [Related]
22. Fraxetin protects rat brains from the cerebral stroke
Cui Y; Liu M; Zuo L; Wang H; Liu J
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):400-409. PubMed ID: 35285387
[TBL] [Abstract][Full Text] [Related]
23. Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.
Wang H; Xu X; Yin Y; Yu S; Ren H; Xue Q; Xu X
Phytomedicine; 2020 Nov; 78():153300. PubMed ID: 32866905
[TBL] [Abstract][Full Text] [Related]
24. Icariin and mesenchymal stem cells synergistically promote angiogenesis and neurogenesis after cerebral ischemia via PI3K and ERK1/2 pathways.
Liu D; Ye Y; Xu L; Yuan W; Zhang Q
Biomed Pharmacother; 2018 Dec; 108():663-669. PubMed ID: 30245466
[TBL] [Abstract][Full Text] [Related]
25. Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
Zhu J; Jin Z; Yang L; Zhao C; Hu J; Chen J; Han Y; Yu P; Luo J; Kong L; Zhang C
Pharmacol Res; 2022 Jun; 180():106240. PubMed ID: 35513225
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice.
Ates N; Caglayan A; Balcikanli Z; Sertel E; Beker MC; Dilsiz P; Caglayan AB; Celik S; Dasdelen MF; Caglayan B; Yigitbasi T; Ozbek H; Doeppner TR; Hermann DM; Kilic E
Exp Neurol; 2022 May; 351():113996. PubMed ID: 35122865
[TBL] [Abstract][Full Text] [Related]
27. Salidroside promotes angiogenesis after cerebral ischemia in mice through Shh signaling pathway.
Li Y; Xue W; Li S; Cui L; Gao Y; Li L; Chen R; Zhang X; Xu R; Jiang W; Zhang X; Wang L
Biomed Pharmacother; 2024 May; 174():116625. PubMed ID: 38643543
[TBL] [Abstract][Full Text] [Related]
28. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling.
Zhang W; Song JK; Yan R; Li L; Xiao ZY; Zhou WX; Wang ZZ; Xiao W; Du GH
Acta Pharmacol Sin; 2018 Aug; 39(8):1259-1272. PubMed ID: 29542683
[TBL] [Abstract][Full Text] [Related]
29. Shengui Sansheng San extraction is an angiogenic switch via regulations of AKT/mTOR, ERK1/2 and Notch1 signal pathways after ischemic stroke.
Liu B; Luo C; Zheng Z; Xia Z; Zhang Q; Ke C; Liu R; Zhao Y
Phytomedicine; 2018 May; 44():20-31. PubMed ID: 29895489
[TBL] [Abstract][Full Text] [Related]
30. TSLP/TSLPR promote angiogenesis following ischemic stroke via activation of the PI3K/AKT pathway.
Yu X; Peng Y; Liang H; Fu K; Zhao Z; Xie C; Zhou L; Zhang K
Mol Med Rep; 2018 Feb; 17(2):3411-3417. PubMed ID: 29257253
[TBL] [Abstract][Full Text] [Related]
31. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription.
Fernández JG; Rodríguez DA; Valenzuela M; Calderon C; Urzúa U; Munroe D; Rosas C; Lemus D; Díaz N; Wright MC; Leyton L; Tapia JC; Quest AF
Mol Cancer; 2014 Sep; 13():209. PubMed ID: 25204429
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke.
Bai Q; Lyu Z; Yang X; Pan Z; Lou J; Dong T
Behav Brain Res; 2017 Mar; 321():79-86. PubMed ID: 28042007
[TBL] [Abstract][Full Text] [Related]
33. Astragaloside IV promotes cerebral angiogenesis and neurological recovery after focal ischemic stroke in mice via activating PI3K/Akt/mTOR signaling pathway.
Shi G; Chen J; Zhang C; Zhao X; Wang J; Chen R; Xu R; Song D; Zhang X
Heliyon; 2023 Dec; 9(12):e22800. PubMed ID: 38089988
[TBL] [Abstract][Full Text] [Related]
34. The three-phase enriched environment paradigm promotes neurovascular restorative and prevents learning impairment after ischemic stroke in rats.
Zhan Y; Li MZ; Yang L; Feng XF; Lei JF; Zhang N; Zhao YY; Zhao H
Neurobiol Dis; 2020 Dec; 146():105091. PubMed ID: 32979506
[TBL] [Abstract][Full Text] [Related]
35. Buyang huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage.
Cui HJ; Yang AL; Zhou HJ; Wang C; Luo JK; Lin Y; Zong YX; Tang T
BMC Complement Altern Med; 2015 Mar; 15():91. PubMed ID: 25886469
[TBL] [Abstract][Full Text] [Related]
36. Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis.
Jia H; Qi X; Wu H; Wang J
CNS Neurol Disord Drug Targets; 2023; 22(4):607-613. PubMed ID: 35352641
[TBL] [Abstract][Full Text] [Related]
37. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic time window for treatment of focal cerebral ischemia reperfusion injury with XQ-1h in rats.
Sun J; Li Y; Fang W; Mao L
Eur J Pharmacol; 2011 Sep; 666(1-3):105-10. PubMed ID: 21645512
[TBL] [Abstract][Full Text] [Related]
39. BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats.
Chang J; Yao X; Zou H; Wang L; Lu Y; Zhang Q; Zhao H
J Ethnopharmacol; 2016 Dec; 194():1032-1042. PubMed ID: 27833029
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate Kinase M2 Increases Angiogenesis, Neurogenesis, and Functional Recovery Mediated by Upregulation of STAT3 and Focal Adhesion Kinase Activities After Ischemic Stroke in Adult Mice.
Chen D; Wei L; Liu ZR; Yang JJ; Gu X; Wei ZZ; Liu LP; Yu SP
Neurotherapeutics; 2018 Jul; 15(3):770-784. PubMed ID: 29869055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
